Log in

NYSE:WATWaters Stock Price, Forecast & News

$180.82
+0.67 (+0.37 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$180.70
Now: $180.82
$183.80
50-Day Range
$174.76
MA: $189.26
$208.93
52-Week Range
$154.39
Now: $180.82
$245.68
Volume438,100 shs
Average Volume602,898 shs
Market Capitalization$11.19 billion
P/E Ratio22.24
Dividend YieldN/A
Beta0.94
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Read More
Waters logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.7Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$11.18 per share
Book Value($3.36) per share

Profitability

Net Income$592.20 million

Miscellaneous

Employees7,500
Market Cap$11.19 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

Waters (NYSE:WAT) Frequently Asked Questions

How has Waters' stock been impacted by COVID-19 (Coronavirus)?

Waters' stock was trading at $184.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WAT shares have decreased by 1.8% and is now trading at $180.82. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Waters?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 5 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for Waters.

When is Waters' next earnings date?

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Waters.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) issued its quarterly earnings data on Tuesday, April, 28th. The medical instruments supplier reported $1.15 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $1.39 by $0.24. The medical instruments supplier earned $464.94 million during the quarter, compared to analyst estimates of $480.07 million. Waters had a return on equity of 1,937.83% and a net margin of 22.77%. The company's revenue was down 9.5% on a year-over-year basis. During the same period last year, the business earned $1.60 earnings per share. View Waters' earnings history.

What price target have analysts set for WAT?

9 equities research analysts have issued 1 year price targets for Waters' stock. Their forecasts range from $145.00 to $212.00. On average, they anticipate Waters' stock price to reach $176.38 in the next year. This suggests that the stock has a possible downside of 2.5%. View analysts' price targets for Waters.

Has Waters been receiving favorable news coverage?

News articles about WAT stock have been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a news sentiment score of 0.7 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Waters.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Home Depot (HD), CVS Health (CVS), Raytheon Technologies (RTX), Alibaba Group (BABA), Verizon Communications (VZ), Cisco Systems (CSCO), Walmart (WMT) and CSX (CSX).

Who are Waters' key executives?

Waters' management team includes the following people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $180.82.

How big of a company is Waters?

Waters has a market capitalization of $11.19 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,500 workers across the globe.

What is Waters' official website?

The official website for Waters is www.waters.com.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.